WA
ALXN

WFG Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

WFG Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$0 Hold
1
– – ﹤0.01% 1709
2017
Q1 		$0 Hold
1
– – ﹤0.01% 1718
2016
Q4 		$0 Sell
1
-6
-86% -$734 ﹤0.01% 1784
2016
Q3 		$1K Hold
7
– – ﹤0.01% 1525
2016
Q2 		$1K Hold
7
– – ﹤0.01% 1517
2016
Q1 		$1K Buy
7
+1
+17% +$147 ﹤0.01% 1480
2015
Q4 		$1K Hold
6
– – ﹤0.01% 1517
2015
Q3 		$1K Hold
6
– – ﹤0.01% 1548
2015
Q2 		$1K Hold
6
– – ﹤0.01% 1611
2015
Q1 		$1K Sell
6
-170
-97% -$30.8K ﹤0.01% 1686
2014
Q4 		$33K Hold
176
– – 0.01% 1057
2014
Q3 		$29K Sell
176
-400
-69% -$65.7K 0.01% 1143
2014
Q2 		$90K Hold
576
– – 0.02% 696
2014
Q1 		$88K Hold
576
– – 0.02% 688
2013
Q4 		$77K Buy
576
+500
+658% +$60K 0.01% 845
2013
Q3 		$9K Hold
76
– – ﹤0.01% 1576
2013
Q2 		$7K Buy
+76
New +$7.32K ﹤0.01% 1583

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return